'Committed': NBC News Freelancer Returned to Liberia Despite Ebola Risk

This version of Committed Nbc News Freelancer Returned Liberia Despite Ebola Risk N217791 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

Ashoka Mukpo is the fifth American diagnosed with Ebola after contracting it while working in Liberia. Friends say he has a passion for the country.
Get more newsCommitted Nbc News Freelancer Returned Liberia Despite Ebola Risk N217791 - Breaking News | NBC News Cloneon

Journalist Ashoka Mukpo knew the dangers of returning to Liberia, but friends say the chance to spotlight its struggles was worth the risk.

Mukpo, 33, became the fifth American diagnosed with Ebola, it was announced Thursday, after he begun working as a freelance cameraman for NBC News this week. The revelation has left his family and friends reeling — knowing how he was willing to be in the epicenter of an illness that has killed more than 3,000 people in West Africa.

Mukpo’s father, Dr. Mitchell Levy, told the TODAY show on Friday that his son is “scared and worried ... but his spirits are better today.” Mukpo is showing mild symptoms of the virus, and will be flown back Sunday to the United States for treatment at The Nebraska Medical Center in Omaha, the hospital confirmed. It’s unclear exactly how he contracted the deadly disease, but he had been writing freelance stories from the front lines of the outbreak.

Slide 1 of 1

In a Facebook post on Sept. 5, Mukpo wrote that he was back in Liberia and being careful: “I am taking serious precautions and washing with chlorine regularly. The virus only passes through open cuts and membranes like eyes and mouth so with gloves, chlorine washes, and care to not touch anyone there’s a low risk of transmission.”

Mukpo is a devout, converted Buddhist from Rhode Island, and has a passion for Liberian culture, friends say. Philip Marcelo, a Boston-based Associated Press reporter, met him last year while on assignment in Liberia for The Providence Journal. Marcelo says Mukpo was a researcher for the Sustainable Development Institute, a Liberia-based nonprofit shining light on concerns of workers in mining camps outside Monrovia.

Slide 1 of 1

Mukpo had also spent two months in 2011 working with a Non-Governmental Organization in Liberia providing AIDS prevention services, said friend Adam Hutton. The two were also roommates in Brooklyn, N.Y., while Mukpo was in graduate school at Columbia University studying international and public affairs. “He cares very deeply about injustice in the world, he saw a lot of that in Liberia," Hutton told NBC News. "I think he was motivated to do something about it.”

Chad Bilyeu, a friend and former classmate, told NBC affiliate NECN about their shared passion for hip-hop and Mukpo’s desire to help people. Bilyeu met Mukpo at Georgetown University in Washington, D.C. “I just always knew him as a very thoughtful, caring person," Bilyeu said. “I saw that the studies, and his interest in Africa, was very altruistic.”

Friends and family are hopeful that Mukpo will improve once he’s back in the United States. Other Americans who have fallen ill in West Africa and treated here have fully recovered, and friends say Mukpo is a fighter. “As a journalist, Ashoka has worked as a freelancer, which is a tremendous grind under the best circumstances,” Hutton said, adding, “The man contracted a deadly disease in service of a story, I’d say he’s committed.”

IN-DEPTH

SOCIAL

— Erik Ortiz

The Associated Press contributed to this report.

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone